Great West Life Assurance CO Vaxcyte, Inc. Transaction History
Great West Life Assurance CO
- $49.6 Billion
- Q1 2024
A detailed history of Great West Life Assurance CO transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 18,064 shares of PCVX stock, worth $1.41 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,064
Previous 6,856
163.48%
Holding current value
$1.41 Million
Previous $428,000
188.32%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding PCVX
# of Institutions
268Shares Held
97.1MCall Options Held
202KPut Options Held
147K-
Vanguard Group Inc Valley Forge, PA9.74MShares$757 Million0.01% of portfolio
-
Black Rock Inc. New York, NY9.51MShares$740 Million0.02% of portfolio
-
Janus Henderson Group PLC London, X07.67MShares$597 Million0.29% of portfolio
-
Wellington Management Group LLP Boston, MA4.92MShares$383 Million0.06% of portfolio
-
Capital Research Global Investors Los Angeles, CA4.14MShares$322 Million0.07% of portfolio
About Vaxcyte, Inc.
- Ticker PCVX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,315,100
- Market Cap $4.61B
- Description
- Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...